<DOC>
	<DOCNO>NCT01793012</DOCNO>
	<brief_summary>Infections critical factor survival critically ill patient . A broad , high-dose early initial therapy antibiotic particular relevance . A serious problem high variability antibiotic serum concentration administration antibiotic patient critical care unit . This may result risk underdosage possible ineffective therapeutic level well risk overdosage possible adverse toxic effect . The goal study determine antibiotic concentration blood evaluate concentration course therapy . The measurement antibiotic concentration blood may allow individual adaption dose future . 100 - 200 patient include study . Only critically ill patient ICU Department Anaesthesiology include receive one follow antibiotic : piperacillin/tazobactam , cefepime , meropenem , ciprofloxacin , linezolid , colistin .</brief_summary>
	<brief_title>Drug Monitoring Antibiotics Critical Care Patients</brief_title>
	<detailed_description>Substantial variation serum concentration different antibiotic partly insufficient level observe critically ill patient . The high variability pharmacokinetic parameter different patient argue therapeutic drug monitoring ( TDM ) intensive care unit . TDM may lower risk overdosage possible adverse toxic effect well risk underdosage possible insufficient therapeutic effect development antibiotic resistance . The aim study evaluate variability pharmacokinetic parameter different widely use antibiotic correlate clinical laboratory parameter . Therefore , numerous clinical laboratory parameter include serum , urine dialysate concentration 6 different antibiotic determine 100 - 200 critically ill patient Department Anaesthesiology , University Hospital Munich . Laboratory parameter ( e.g . inflammatory parameter ) quantify facility Institute Laboratory Medicine , University Hospital Munich . Concentrations antibiotic determine liquid chromatography-mass spectrometry ( LC-MS/MS ) . We expect correlation antibiotic serum concentration clinical laboratory outcome parameter find .</detailed_description>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Hospitalisation critical care unit Department Anaesthesiology University Hospital Munich 2 . Presence infection clinical assessment 3 . Treatment patient one follow antibiotic : piperacillin/tazobactam , cefepime , meropenem , ciprofloxacin , linezolid , colistin 4 . Bolus administration select antibiotic 5 . Valid inform consent subscribe patient legal guardian provisional guardian define provisional guardian . 1 . Prophylactic antibiotic without clinical assessment presence infection 2 . Planned short hospital stay 4 day 3 . Administration select antibiotic 14 day 48 hour begin study 4 . Only single dose antibiotic per day 5 . Subsequent withdrawal participation study patient guardian</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>therapeutic drug monitoring</keyword>
	<keyword>antibiotic</keyword>
	<keyword>inflammation parameter</keyword>
	<keyword>critically ill patient</keyword>
	<keyword>septicaemia</keyword>
	<keyword>intensive care unit</keyword>
</DOC>